ASPE — Aspen Neuroscience, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 2124080 ·
Last close
$12.00
Market Cap
$348.94M
52W High
$14.90
52W Low
$11.20
ADV30
379,255
Next earnings
—
Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases. The company's develops ANPD001, an investigational single-dose, autologous dopaminergic neuronal precursor cell (DANPC) therapy for Parkinson's disease. It operates in the United States. The company also advances additional cell replacement candidates targeting both sporadic and genetic forms of Parkinson's disease, as well as other candidates for conditions of the central nervous system (CNS). Aspen Neuroscience, Inc. was formerly known as Aspen Biosciences, Inc. and changed its name to Aspen Neuroscience, Inc. in October 2018. Aspen Neuroscience, Inc. was incorporated in 2018 and is based in San Diego, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 110,275,000 21,287,000 361,348,000
Dec 2025 — — — — 143,663,000 82,097,000 360,740,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-264,886,000
Inventory
—
Receivables
—
ST Investments
$51,090,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -59,305,000 -62,056,000 143,663,000 360,740,000 -217,077,000 -52,847,000
Dec 2024 0 -53,458,000 -48,557,000 90,211,000 247,938,000 -157,727,000 -44,162,000

Peers — same industry

TickerNameMarket CapLastDaily %
VREOF Vireo Growth Inc. $346.76M $6.01 —
CTNM Contineum Therapeutics, Inc. $337.62M $9.55 —
LYEL Lyell Immunopharma, Inc. $336.08M $13.67 —
PEPG PepGen Inc. $365.73M $3.88 —
CYDY CytoDyn Inc. $366.64M $0.25 —

News headlines (Yahoo Finance, 1h cache)

At $215, Moderna Stock Already Prices In A Comeback
2026-11-17 10:38 · Yahoo
Should You Buy Neurocrine Biosciences Stock For Its Cash?
2026-11-16 11:42 · Yahoo
The Single Most Important Metric For Moderna Stock
2026-11-13 20:12 · Yahoo
What Is Behind The Rise In Moderna Stock?
2026-11-07 12:49 · Yahoo
Which Dates Could Move Moderna Stock Most?
2026-11-04 21:56 · Yahoo
Aspen Neuroscience Announces Pricing of Initial Public Offering
2026-10-30 02:12 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.